Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
Kenneth G Saag, Rachel B Wagman, Piet Geusens, Jonathan D Adachi, Osvaldo D Messina, Ronald Emkey, Roland Chapurlat, Andrea Wang, Nicola Pannacciulli, Willem F Lems
Acceder al Archivo
